Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119881 | NOVABASE SGPS SA (NBAU.TU) | TRQX | PT | 2022-12-31 | 2 months ago | EUR | 0.00 | 2.89 | 0.00% | 0.50 | 0.00% | NCAV (Net-Net) | 0.50 | 0.00% |
| 119882 | NOVABASE SGPS SA (NVQ.DU) | XDUS | PT | 2022-12-31 | 2 days ago | EUR | 6.30 | 2.89 | 45.87% | 0.50 | 7.86% | NCAV (Net-Net) | 0.50 | 7.86% |
| 119883 | NOVABASE SGPS SA (NVQ.F) | XFRA | PT | 2022-12-31 | 6 days ago | EUR | 6.40 | 2.89 | 45.16% | 0.50 | 7.74% | NCAV (Net-Net) | 0.50 | 7.74% |
| 119884 | NOVABASE SGPS SA (NVQ.MU) | XMUN | PT | 2022-12-31 | 1 week ago | EUR | 6.45 | 2.89 | 44.81% | 0.50 | 7.68% | NCAV (Net-Net) | 0.50 | 7.68% |
| 119885 | NOVABASE SGPS SA (NVQ.SG) | XSTU | PT | 2022-12-31 | 1 month ago | EUR | 6.20 | 2.89 | 46.61% | 0.50 | 7.98% | NCAV (Net-Net) | 0.50 | 7.98% |
| 119886 | NovaBay Pharmaceuticals Inc (B9P.BE) | XBER | US | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119887 | NovaBay Pharmaceuticals Inc (B9P.BE) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 119888 | NovaBay Pharmaceuticals Inc (B9P.DU) | XDUS | US | 2023-12-31 | 6 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119889 | NovaBay Pharmaceuticals Inc (B9P.F) | XFRA | US | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119890 | NovaBay Pharmaceuticals Inc (B9P.MU) | XMUN | US | 2023-12-31 | 6 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |